Full-Time

Senior Scientist

PhD, Immunology/T-Cell Biology

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Biotechnology
Healthcare

Compensation Overview

$88.3k - $147.1kAnnually

+ Bonus

Senior

La Jolla, San Diego, CA, USA + 1 more

More locations: United States

Work Location Assignment: On Premise; Relocation assistance may be available.

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD, in cancer biology, tumor immunology, immunology or a related field with 2+ years of relevant postdoctoral experience in an academic or pharmaceutical/biotech environment
  • A desire to continue in a laboratory-focused role and develop innovative methods to evaluate biological therapeutics for their impact on target biology and immune modulation
  • Expertise in tumor biology or immunology as evidenced by publication in peer-reviewed journals
  • Demonstrated proficiency in a wide range of immune assays and cellular techniques including mammalian cell culture, multicolor flow cytometry/FACS to immunophenotype murine and human cells from blood and tissues, and cytokine measurements from serum/plasma (MSD, Luminex, ELISA)
  • Strong knowledge of T cell biology with technical expertise in T cell-based functional assays (e.g. activation, differentiation, proliferation)
  • Strong ability to multi-task and work independently and efficiently in a fast-paced, highly collaborative in a diverse team environment with excellent communication skills and excellent leadership skills
Responsibilities
  • Independently design, execute and analyze/interpret experiments to evaluate mechanism of action, elucidate mechanisms of resistance, and identify rational drug combinations that will advance preclinical and clinical stage IO programs
  • Participate at the project team level as a subject matter expert and effectively collaborate with other members of the Oncology Research Unit, including early research and discovery biology, computational biology, in vivo pharmacology, toxicology and drug pharmacokinetics teams
  • Proactively seek out novel methods in the literature and incorporate learnings to progress preclinical research and develop new experimental ways of testing hypotheses
  • Present research results and methodologies at routine meetings with immediate supervisor and/or project leader, project team meetings and other research forums
  • Forecast and plan resource requirements to meet the research goals as part of the project team
  • Record experimental protocols/results in detail and may write technical reports for regulatory filings
  • Supervise and mentor junior colleagues in experimental assay design, execution, and analysis
  • May occasionally engage and work with external collaborations and Contract Research Organizations (CROs)
  • Contribute to building a culture that embraces scientific excellence, urgency, partnerships with key stakeholders, continuous learning and improvement, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The goal of Pfizer is to enhance global health by expanding its range of effective treatments and vaccines.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships accelerate novel cancer therapies development, especially in multiple myeloma.
  • Increased investment in AI enhances Pfizer's R&D efficiency and innovation.
  • Pfizer's financing in immunotherapies and fibrosis treatments expands its future pipeline.

What critics are saying

  • Decreased demand for COVID-19 vaccines impacts Pfizer's revenue streams.
  • Activist investor stake may pressure Pfizer for strategic changes, causing instability.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • The company focuses on innovative medicines and vaccines for global distribution.
  • Pfizer invests in AI-driven drug discovery to enhance R&D efficiency.

Help us improve and share your feedback! Did you find this helpful?